Challenging cases in plaque psoriasis – optimising outcomes

Australie

$0

gratuit

RACP

1.0 hr

Dermatology

1 Credits

This course is expired! Browse All Courses
APPRENDRE ENCORE PLUS

Description du cours

This 1-hour RACP accredited activity program is designed to provide dermatologists with a contemporary clinical approach to the management of plaque psoriasis, with the aim of optimising outcomes for their patients. The program will help dermatologists explore the efficacy and safety of novel targeted therapies such as ixekizumab in plaque psoriasis.

This educational activity was developed by MdBriefCase at the request, and with funding from Eli Lilly.

Détails du cours

Date d'expiration : 2022-12-31

Métiers: Spécialiste

Faculté

Prof. Peter Foley,
BMedSc, MBBS, MD, FACD

Accréditation

This interactive online learning activity is valued at 1 Hour(s) of continuing education with RACP.

Objectif(s) d'apprentissage

Upon completion of this continuing education program participants will be better able to:

  • Décrire the advantages in pursuing a treatment plan with a goal of achieving a Psoriasis Area Severity Index (PASI) 100 response
  • Evaluate efficacy and safety of novel targeted therapies such as ixekizumab in plaque psoriasis
  • Identifier patients with plaque psoriasis who would most benefit from treatment with ixekizumab
This course is expired! Browse All Courses